All Stories

  1. A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV Variants
  2. Differential Regulation of NF-κB-Mediated Proviral and Antiviral Host Gene Expression by Primate Lentiviral Nef and Vpu Proteins
  3. Viral Etiology of Respiratory Tract Infections in Children at the Pediatric Hospital in Ouagadougou (Burkina Faso)
  4. Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy
  5. Genotypic resistance profiles of HIV-2-treated patients in West Africa
  6. Field evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo immunoassay
  7. Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France
  8. Non-M Variants of Human Immunodeficiency Virus Type 1
  9. A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure
  10. Algorithm-Based Prediction of HIV-1 Subtype D Coreceptor Use
  11. Kinetics of relapse after pegylated interferon and ribavirin therapy for chronic hepatitis C
  12. Cross-group neutralization of HIV-1 and evidence for conservation of the PG9/PG16 epitopes within divergent groups
  13. The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection
  14. Raltegravir-Based Regimens Are Effective in HIV-1 Group O–Infected Patients
  15. HIV-1 group N: travelling beyond Cameroon
  16. Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France
  17. Comparative RNA Quantification of HIV-1 Group M and Non-M With the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR Assays
  18. Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study
  19. Impact of HIV-1 Group O Genetic Diversity on Genotypic Resistance Interpretation by Algorithms Designed for HIV-1 Group M
  20. HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef
  21. Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare Setting
  22. Passages inter-espèces des virus de l’immunodéficience humaine et simienne chez les primates
  23. First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon
  24. HIV contamination of commercial PCR enzymes raises the importance of quality control of low-cost in-house genotypic HIV drug resistance tests
  25. Diagnosis and Monitoring of HIV-1 Group O-Infected Patients in Cameroun
  26. A new human immunodeficiency virus derived from gorillas
  27. High HIV Type 1 Prevalence and Wide Genetic Diversity with Dominance of Recombinant Strains But Low Level of Antiretroviral Drug-Resistance Mutations in Untreated Patients in Northeast Gabon, Central Africa
  28. HIV-1 and HIV-2 produce different amounts of 2-long terminal repeat circular DNA in vitro
  29. Unequal Detection of HIV Type 1 Group O Infection by Simple Rapid Tests
  30. Integrase polymorphism and HIV-1 group O diversity
  31. Monitoring of HIV-1 Resistance in Tunisia (North Africa) With a Dried Plasma Spot Strategy
  32. Differences in proviral DNA load between HIV-1- and HIV-2-infected patients
  33. Monitoring the Dynamics of the HIV Epidemic Using Assays for Recent Infection and Serotyping among New HIV Diagnoses: Experience after 2 Years in France
  34. Impact of HIV-1 Genetic Diversity on Plasma HIV-1 RNA Quantification
  35. Prevalence of HIV-1 Drug Resistance in Treated Patients
  36. Evaluation of the Roche Cobas TaqMan and Abbott RealTime Extraction-Quantification Systems for HIV-1 Subtypes
  37. Generic screening test for HIV infection
  38. Molecular epidemiology of hepatitis B virus in Dakar, Sénégal
  39. Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic
  40. Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa
  41. French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002
  42. HIV-1 resistance genotyping on dried serum spots
  43. Phenotypic Susceptibility to Nonnucleoside Inhibitors of Virion-Associated Reverse Transcriptase From Different HIV Types and Groups
  44. Virologic Diagnosis and Follow-up of Children Born to Mothers Infected by HIV-1 Group O
  45. Plasma viral RNA assay in HIV-1 group O infection by real-time PCR
  46. Plasma RNA Quantification and HIV-1 Divergent Strains
  47. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes
  48. Variability of Human Immunodeficiency Virus Type 2 (HIV-2) Infecting Patients Living in France
  49. V3 Serotyping of HIV-1 Infection: Correlation With Genotyping and Limitations
  50. Monitoring HIV-1 Subtype Distribution